These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18322282)

  • 1. A Parkinsonian syndrome in methcathinone users and the role of manganese.
    Stepens A; Logina I; Liguts V; Aldins P; Eksteina I; Platkājis A; Mārtinsone I; Tērauds E; Rozentāle B; Donaghy M
    N Engl J Med; 2008 Mar; 358(10):1009-17. PubMed ID: 18322282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology.
    Stepens A; Groma V; Skuja S; Platkājis A; Aldiņš P; Ekšteina I; Mārtiņsone I; Bricis R; Donaghy M
    Eur J Neurol; 2014 Feb; 21(2):199-205. PubMed ID: 23678867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage.
    Sikk K; Taba P
    Int Rev Neurobiol; 2015; 120():257-71. PubMed ID: 26070761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow-up.
    Sikk K; Haldre S; Aquilonius SM; Asser A; Paris M; Roose Ä; Petterson J; Eriksson SL; Bergquist J; Taba P
    Eur J Neurol; 2013 Jun; 20(6):915-20. PubMed ID: 23347399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse.
    de Bie RM; Gladstone RM; Strafella AP; Ko JH; Lang AE
    Arch Neurol; 2007 Jun; 64(6):886-9. PubMed ID: 17562938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic manganese intoxication due to methcathinone (ephedron) abuse: a case report].
    Yildirim EA; Eşsizoğlu A; Köksal A; Doğu B; Baybaş S; Gökalp P
    Turk Psikiyatri Derg; 2009; 20(3):294-8. PubMed ID: 19757228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity following chronic intravenous use of "Russian cocktail".
    Varlibas F; Delipoyraz I; Yuksel G; Filiz G; Tireli H; Gecim NO
    Clin Toxicol (Phila); 2009 Feb; 47(2):157-60. PubMed ID: 18608260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Encephalopathy caused by intravenous potassium permanganate used for illegal production of methcathinone (ephedrone) from medicines containing pseudoephedrine].
    Habrat B; Baran-Furga H; Sienkiewicz-Jarosz H; Sein Anand J; Poniatowska R
    Przegl Lek; 2013; 70(8):613-6. PubMed ID: 24466704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism.
    Djamshidian A; Sanotsky Y; Matviyenko Y; O'Sullivan SS; Sharman S; Selikhova M; Fedoryshyn L; Filts Y; Bearn J; Lees AJ; Averbeck BB
    Addiction; 2013 Apr; 108(4):771-9. PubMed ID: 23228208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganic encephalopathy due to "ephedrone" abuse.
    Sanotsky Y; Lesyk R; Fedoryshyn L; Komnatska I; Matviyenko Y; Fahn S
    Mov Disord; 2007 Jul; 22(9):1337-43. PubMed ID: 17566121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome.
    Juurmaa J; Menke RA; Vila P; Müürsepp A; Tomberg T; Ilves P; Nigul M; Johansen-Berg H; Donaghy M; Stagg CJ; Stepens A; Taba P
    Brain Behav; 2016 Nov; 6(11):e00539. PubMed ID: 27843694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of reward and effort sensitivity in methcathinone-induced Parkinsonism.
    Chong TT; Bonnelle V; Veromann KR; Juurmaa J; Taba P; Plant O; Husain M
    J Neuropsychol; 2018 Jun; 12(2):291-297. PubMed ID: 28378511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse.
    Selikhova M; Tripoliti E; Fedoryshyn L; Matvienko Y; Stanetska H; Boychuk M; Komnatska I; Lees AJ; Sanotsky Y
    Clin Neurol Neurosurg; 2016 Aug; 147():71-7. PubMed ID: 27310289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome.
    Stepens A; Stagg CJ; Platkajis A; Boudrias MH; Johansen-Berg H; Donaghy M
    Brain; 2010 Dec; 133(Pt 12):3676-84. PubMed ID: 21036949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism caused by chronic usage of intravenous potassium permanganate.
    Meral H; Kutukcu Y; Atmaca B; Ozer F; Hamamcioglu K
    Neurologist; 2007 Mar; 13(2):92-4. PubMed ID: 17351530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A patient with parkinsonism presenting hyperintensity in the globus pallidus on T1-weighted MR images: the correlation with manganese poisoning].
    Katsuragi T; Takahashi T; Shibuya K; Nagatomo H; Iwabuchi K
    Rinsho Shinkeigaku; 1996 Jun; 36(6):780-2. PubMed ID: 8937201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methcathinone-induced parkinsonism results from permanent brain damage: a message for the masses.
    Fasano A
    Eur J Neurol; 2014 Feb; 21(2):181-2. PubMed ID: 23834461
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity.
    Josephs KA; Ahlskog JE; Klos KJ; Kumar N; Fealey RD; Trenerry MR; Cowl CT
    Neurology; 2005 Jun; 64(12):2033-9. PubMed ID: 15888601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive dysfunctions caused by excessive exposure to manganese compounds. Cognitive disturbances in intravenous users of ephedrone (methcathinone) with manganese compounds].
    Kałwa A; Habrat B
    Psychiatr Pol; 2015; 49(2):305-14. PubMed ID: 26093594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine as a material for evaluation of exposure to manganese in methcathinone users.
    Golasik M; Wodowski G; Gomółka E; Herman M; Piekoszewski W
    J Trace Elem Med Biol; 2014 Jul; 28(3):338-43. PubMed ID: 24867657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.